Skip to main content

Web Content Display Web Content Display

Skip banner

Breadcrumb Breadcrumb

Web Content Display Web Content Display

January 2019

20190110
Previous week
Next week

A new call on Personalised Medicine for Neurodegenerative Diseases

Date: 10.01.2019 - 12.03.2019
A new call on Personalised Medicine for Neurodegenerative Diseases

Announcing Institution:

National Science Centre

Object of the call:

Neurodegenerative diseases are debilitating and still largely untreatable conditions. They are characterised by a large variability in their origins, mechanisms and clinical expression. When searching for a medical solution, e.g. a treatment or an optimised approach for care, this large variability constitutes a major hurdle if not controlled. Indeed a treatment addressing one disease pathway may not be useful for all patients experiencing the relevant symptoms. Thus, one of the greatest challenges for treating neurodegenerative diseases is the deciphering of this variability.

Call supervisor at CAWP:

Agnieszka Kołodziejska-Skrobek
phone: 12 663 30 23,
e‑mail: agnieszka.kolodziejska-skrobek@uj.edu.pl

The following neurodegenerative diseases are included in the call:

  • Alzheimer’s disease and other dementias
  • Parkinson’s disease and PD‐related disorders
  • Prion diseases
  • Motor neuron diseases
  • Huntington’s disease
  • Spinocerebellar ataxia (SCA)
  • Spinal muscular atrophy (SMA)

JPND has chosen to focus in the area of Precision Medicine, which relates to the targeting of specific elements responsible for pathology in a given individual at a particular point in time. It is an emerging approach for disease prevention, diagnosis and treatment that takes into account individual variability in genes, biological/molecular characteristics together with environmental and lifestyle factors.

Thus, the call focuses on Precision Medicine in the following research areas:

  • Diagnosis (e.g. biomarkers, imaging data, omics approaches, big data analyses)
  • Prevention (e.g. biomarkers for studying novel treatments and interventions, co-morbidities, digital technologies, stratification within cohort studies and clinical trials)
  • Care (e.g. improvement of social and health care systems, molecular profiling, imaging, lifestyle data)

Application procedure:

A two-stage application procedure (pre-proposals and full proposals) will be open for consortia composed of researchers from at least three countries participating in the call

Deadline:

Deadline for pre-proposal submission: 12th March 2019, 15.00 CET

More information:

NSC

Call webpage

Call text

Pre-proposal template

Pre-proposal guidelines